Opinion: Three traps for the unwary in HHS’ provider relief fund
In its rush to offer a lifeline to U.S. health care providers struggling under the…
Category: coronavirus
14 questions for Fauci, Redfield, and the other Trump officials testifying on the U.S. coronavirus response
The Trump administration figures who’ve led the federal government’s coronavirus response have escaped the wrath…
.jpg)
Inside the NIH’s controversial decision to stop its big remdesivir study
The drug maker Gilead Sciences released a bombshell two weeks ago: A study conducted by…
Trump administration announces plan to distribute Covid-19 drug amid concerns over allocation
WASHINGTON — The federal government on Saturday announced a plan to distribute remdesivir, the antiviral…
.jpg)
7 questions about Covid-19 testing and what it means for reopening the country
Pressure to perform widespread Covid-19 testing is growing as public health experts and ordinary citizens…
Routine vaccinations for U.S. children have plummeted during the Covid-19 pandemic
Routine vaccination of children in the United States appeared to have declined dramatically in March…
Opinion: Acknowledging the public role in private drug development: lessons from remdesivir
The quest for vaccines and therapeutic treatments against Covid-19 shouldn’t be complicated or delayed by…
The U.S. government contributed research to a Gilead remdesivir patent — but didn’t get credit
Two documents dating back to 2015 shed further light on the role the federal government…
Opinion: What the Covid-19 pandemic is teaching us about community
“There is no power for change greater than a community discovering what it cares about.”…
Opinion: Nursing homes, veterans’ homes are national epicenters of Covid-19
It is only Saturday afternoon and our emergency department has already seen the fourth patient…
The porn industry tests and traces. Could it offer a model for reopening amid Covid-19?
LOS ANGELES — As states and employers furiously develop plans to safely reopen workplaces in…
Listen: How bad will the pandemic get? Plus: Gilead’s pricing dilemma and fighting Covid-19 in New York
What if the curve just stays flat? How much should a Covid-19 drug cost? And…
A snapshot of coronavirus in the U.S.: A high plateau of new cases portends more spread
For all the talk of a second wave of coronavirus cases hitting the United States…
Digital event: Confronting a Pandemic — Part 1
Editor’s note: The livesteam will be embedded below at 2:30 p.m. ET. The need to…
Opinion: Covid-19 has renewed America’s trust in its doctors. Will it fade when the pandemic is over?
I had a disturbing conversation with my younger sister about the public perception of doctors…
Photos: A peek inside one Boston hospital’s response to Covid-19
This is one in a series of reports from hospitals responding to the Covid-19 pandemic. When he…
Amazon lends its expertise — and its cash — to Covid-19 research
Shipping behemoth Amazon is increasingly throwing its weight into the pandemic response, sharing its staff’s…
Doctors lambaste federal process for distributing Covid-19 drug remdesivir
Hospitals and physicians around the country are sharply criticizing the federal government for the uneven…
Giving blood thinners to severely ill Covid-19 patients is gaining ground
Treating Covid-19 patients with medicines to prevent blood clots might help reduce deaths in patients…
Digital event: Combating Covid-19 — Part 3
Editor’s note: The live stream will be embedded below at 1 p.m ET. The pandemic…
Opinion: Expertise can help save us from Covid-19 — if we use it right
Not long ago, I read a book about the death of expertise. As I think…
Opinion: A lesson on physician activism from Malawi’s legendary Dr. John Chiphangwi
Five years ago, I was a doctoral student studying the history of medicine in Malawi,…
Mounting promises on Covid-19 vaccines are fueling false expectations, experts say
Vaccines to prevent Covid-19 infection are hurtling through development at speeds never before seen. But…
Gilead signals steps to widen global access to remdesivir for Covid-19 patients
Amid questions about access to remdesivir, its treatment for Covid-19, Gilead Sciences (GILD) says it…
Vaccine expert says he was punished for raising concerns about Trump’s coronavirus response, nepotism
WASHINGTON — Rick Bright, the ousted head of the Biomedical Advanced Research and Development Authority,…
The fight over facial recognition technology gets fiercer during the Covid-19 pandemic
The long-simmering debate over facial recognition technology is taking on new urgency during the pandemic,…
STAT Plus: CytoDyn CEO made $12M from his stock sale, and his explanation raises more questions
CytoDyn chief executive Nader Pourhassan’s lucrative sale of company stock was confirmed in a regulatory…
Doctors in Europe, New York report rare cases of pediatric inflammatory condition, possibly caused by coronavirus
Fifteen children in New York City have been hospitalized for what officials called a “multi-system…
New CRISPR-based test for Covid-19 could be a simple, cheap at-home diagnostic, scientists say
The revolutionary genetic technique better known for its potential to cure thousands of inherited diseases…
Opinion: After four years of medical school, how am I ‘nonessential’?
As the U.S began slowly grinding to a halt in February and March, we braced…
Were researchers wrong to move the goalposts on remdesivir? In the end, it may not have mattered
Last Wednesday, Gilead announced that its drug, remdesivir, sped the time it took patients to…
Opinion: How biopharma companies can keep ‘feeding the beast’ in the time of coronavirus
My colleagues and I lead and support the finance function of more than 160 biopharma…
Opinion: Intubation boxes: an extra layer of safety or a false sense of security?
SARS-CoV-2, the virus that causes Covid-19, is so infectious that protecting health care workers from…
Efforts to beat back the coronavirus are critical. They’re also making clinical trials harder
In March, a team of Chinese scientists studying whether the antiviral remdesivir was effective against…
Watch: Antibodies, immunity, and what they mean for Covid-19, explained
The immune system is no wimp. When pathogens cause illness, it kicks into high gear….
A cancer patient reconsiders her end-of-life wishes, as Covid-19 brings mortality into sharper focus
Even before she knew what kind of cancer she had, Robin Hodges knew she didn’t…
Opinion: Collateral damage occurs when doctors and patients wear ‘Covid-19 blinders’
My friend Mina had a stroke at home while an infectious disease pandemic raged around…
STAT Plus: Without showing any data, CytoDyn touts treatment for Covid-19 as winner — while its CEO sells stock
While Nader Pourhassan, the chief executive of drug maker CytoDyn, filed his intention to sell…
Opinion: Exercising Bayh-Dole march-in rights would handicap Covid-19 innovation
Scientists across America are working hard to develop treatments for and vaccines against the novel…
Watch: How does Gilead’s experimental drug remdesivir work against the coronavirus?
Gilead Sciences’ experimental drug remdesivir has been gaining traction as a potential Covid-19 treatment, and…
Opinion: Lifesaving ventilators will sit unused without a national data-sharing effort
In Nobel laureate Amartya Sen’s book “Poverty and Famines,” he argues that famines arise not…
Covid-19 has shuttered scientific labs. It could put a generation of researchers at risk
Scientists are skilled at tackling unexpected problems that threaten the integrity of their experiments —…
Crisis counselors, the ‘paramedics of mental health,’ wage a wrenching battle on the coronavirus front lines
Missouri crisis counselor Lauren Ochs was just starting her overnight shift one night last month…
Routine cancer screenings have plummeted during the pandemic, medical records data show
As it became clear in March that the coronavirus was tearing through the U.S., federal…
Opinion: A service trip to Peru offers lessons for treating Covid-19 in the U.S.
In mid-February, just before the reality of Covid-19 took hold in the United States, I…
Lawmaker asks HHS to ensure Gilead’s remdesivir is affordable if U.S. taxpayers funded R&D
Now that preliminary trial results indicate an experimental Gilead Sciences (GILD) drug can successfully treat…
FDA to allow emergency use of Gilead’s Covid-19 drug
The Food and Drug Administration announced Friday that it would permit emergency use of remdesivir,…
Three potential futures for Covid-19: recurring small outbreaks, a monster wave, or a persistent crisis
As epidemiologists attempt to scope out what Covid-19 has in store for the U.S. this…
Opinion: Striking down DACA would eliminate thousands of health care workers, thwarting America’s pandemic response
The health care community has a responsibility to anticipate worst-case scenarios and develop response plans…
STAT Plus: Pharmalittle: Gilead faces remdesivir production challenges; will scientists run out of Covid-19 trial patients?
And so, another working week will soon draw to a close. Not a moment too…